Shigehiro Karashima

1.3k total citations
71 papers, 806 citations indexed

About

Shigehiro Karashima is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Shigehiro Karashima has authored 71 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Endocrinology, Diabetes and Metabolism, 33 papers in Surgery and 13 papers in Molecular Biology. Recurrent topics in Shigehiro Karashima's work include Hormonal Regulation and Hypertension (35 papers), Adrenal and Paraganglionic Tumors (25 papers) and Adrenal Hormones and Disorders (14 papers). Shigehiro Karashima is often cited by papers focused on Hormonal Regulation and Hypertension (35 papers), Adrenal and Paraganglionic Tumors (25 papers) and Adrenal Hormones and Disorders (14 papers). Shigehiro Karashima collaborates with scholars based in Japan and United States. Shigehiro Karashima's co-authors include Takashi Yoneda, Yoshiyu Takeda, Mitsuhiro Kometani, Masashi Demura, Masakazu Yamagishi, Mikiya Usukura, Issey Osaka, Yoshimichi Takeda, Kenji Furukawa and Koshiro Nishimoto and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Shigehiro Karashima

65 papers receiving 795 citations

Peers

Shigehiro Karashima
C. Seifarth Germany
Jaimini Cegla United Kingdom
Jun Honjo Japan
M. Nauck Germany
Shigehiro Karashima
Citations per year, relative to Shigehiro Karashima Shigehiro Karashima (= 1×) peers Oliver Götze

Countries citing papers authored by Shigehiro Karashima

Since Specialization
Citations

This map shows the geographic impact of Shigehiro Karashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigehiro Karashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigehiro Karashima more than expected).

Fields of papers citing papers by Shigehiro Karashima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigehiro Karashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigehiro Karashima. The network helps show where Shigehiro Karashima may publish in the future.

Co-authorship network of co-authors of Shigehiro Karashima

This figure shows the co-authorship network connecting the top 25 collaborators of Shigehiro Karashima. A scholar is included among the top collaborators of Shigehiro Karashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigehiro Karashima. Shigehiro Karashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kometani, Mitsuhiro, et al.. (2024). Effects of the switch from dulaglutide to tirzepatide on glycemic control, body weight, and fatty liver: a retrospective study. Journal of Diabetes & Metabolic Disorders. 23(2). 2105–2113. 3 indexed citations
2.
Kometani, Mitsuhiro, Shigehiro Karashima, Mikiya Usukura, et al.. (2023). A clinical assessment of portable point-of-care testing for quick cortisol assay during adrenal vein sampling. Scientific Reports. 13(1). 22429–22429. 2 indexed citations
3.
Kometani, Mitsuhiro, Takahiro Nohara, Hiroko Ikeda, et al.. (2023). Using telemedicine to manage a patient with a hypertensive emergency due to pheochromocytoma. Endocrinology Diabetes and Metabolism Case Reports. 2023(3).
4.
Kometani, Mitsuhiro, Shigehiro Karashima, Mikiya Usukura, et al.. (2023). Impact of Conducting Adrenal Venous Sampling in the Morning Versus Afternoon in Primary Aldosteronism. Journal of the Endocrine Society. 7(3). bvad007–bvad007. 2 indexed citations
5.
Karashima, Shigehiro, et al.. (2023). Fulminant type 1 diabetes developed after influenza split vaccination. Endocrinology Diabetes and Metabolism Case Reports. 2023(2). 1 indexed citations
6.
Karashima, Shigehiro, Kohei Ogura, Kazuhiro Ogai, et al.. (2023). Impact of gut microbiome on serum IgG4 levels in the general population: Shika-machi super preventive health examination results. Frontiers in Cellular and Infection Microbiology. 13. 1272398–1272398. 2 indexed citations
7.
Karashima, Shigehiro, Kohei Ogura, Mitsuhiro Kometani, et al.. (2023). Impact of gut microbiome on the renin-aldosterone system: Shika-machi Super Preventive Health Examination results. Hypertension Research. 46(10). 2280–2292. 14 indexed citations
9.
Karashima, Shigehiro, Atsushi Hashimoto, Mitsuhiro Kometani, et al.. (2022). Comprehensive Steroid Assay with Non-Targeted Analysis Using Liquid Chromatography Ion Mobility Mass Spectrometry. International Journal of Molecular Sciences. 23(22). 13858–13858. 2 indexed citations
10.
Karashima, Shigehiro, et al.. (2022). Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Worsen after the Administration of Dulaglutide. Medicina. 58(2). 289–289. 1 indexed citations
11.
Hara, Satoshi, Masaki Kawakami, Mitsuhiro Kometani, et al.. (2022). Evaluating tubulointerstitial compartments in renal biopsy specimens using a deep learning-based approach for classifying normal and abnormal tubules. PLoS ONE. 17(7). e0271161–e0271161. 11 indexed citations
12.
Kometani, Mitsuhiro, Akihiro Nomura, Shigehiro Karashima, et al.. (2020). Feasibility of a Novel Mobile C-Reactive Protein–Testing Device Using Gold-Linked Electrochemical Immunoassay: Clinical Performance Study. JMIR mhealth and uhealth. 8(9). e18782–e18782. 5 indexed citations
13.
Hashimoto, Atsushi, Yoshimichi Takeda, Shigehiro Karashima, et al.. (2020). Impact of mineralocorticoid receptor blockade with direct renin inhibition in angiotensin II-dependent hypertensive mice. Hypertension Research. 43(10). 1099–1104. 8 indexed citations
14.
Kometani, Mitsuhiro, Takashi Yoneda, Masashi Demura, et al.. (2019). Genetic and epigenetic analyses of aldosterone-producing adenoma with hypercortisolemia. Steroids. 151. 108470–108470. 10 indexed citations
15.
Karashima, Shigehiro & Takashi Yoneda. (2019). Madelung disease in a 58-year-old man. Canadian Medical Association Journal. 191(2). E48–E48. 2 indexed citations
16.
Karashima, Shigehiro, Toyonobu Tsuda, Yusuke Wakabayashi, et al.. (2017). Ventricular Fibrillation Associated With Dynamic Changes in J-Point Elevation in a Patient With Silent Thyroiditis. Journal of the Endocrine Society. 2(2). 135–139.
17.
Makita, Kohzoh, Koshiro Nishimoto, Shigehiro Karashima, et al.. (2017). A Novel Method: Super-selective Adrenal Venous Sampling. Journal of Visualized Experiments. 33 indexed citations
18.
Hattangady, Namita G., Shigehiro Karashima, Daniela Ponce‐Balbuena, et al.. (2016). Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production. Journal of Molecular Endocrinology. 57(1). 1–11. 30 indexed citations
19.
Yoneda, Takashi, Masashi Demura, Hiroyuki Takata, et al.. (2012). Unilateral Primary Aldosteronism with Spontaneous Remission after Long-Term Spironolactone Therapy. The Journal of Clinical Endocrinology & Metabolism. 97(4). 1109–1113. 19 indexed citations
20.
Yoneda, Takashi, Masashi Demura, Shigehiro Karashima, et al.. (2009). Effect of mineralocorticoid receptor blockade on the renal renin–angiotensin system in Dahl salt-sensitive hypertensive rats. Journal of Hypertension. 27(4). 800–805. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026